Faculty profile

James Perry

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

James Perry

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
13 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,746

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
Journal of neuro-oncology · 2026
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
Journal of neuro-oncology · 2026
Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma
International Journal of Radiation Oncology Biology Physics · 2025

All 36 publications

Latest funding

Pilot RCT study to assess feasibility of "supra-marginal" surgical resection of malignant glioma (G-SUMIT: Glioma Supra Marginal Incision Trial)
CIHR · 2019 · Co-investigator
$378,673
Advanced Neurotherapeutics involving MRI Guidance of Transcranial Focused Ultrasound
CFI · 2017 · Co-investigator
$2,510,000

All 2 grants and awards

36 publications.

Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Moraes FY, Isen J, Perry J, Laperriere N, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Mason WP, Cairncross JG, Roa W, Ding K, O'Callaghan C

Journal of neuro-oncology2026

DOI: 10.1007/s11060-026-05442-5 PMID: 41661466

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Moraes FY, Isen J, Perry J, Laperriere N, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Mason WP, Cairncross JG, Roa W, Ding K, O'Callaghan C

Journal of neuro-oncology2026

DOI: 10.1007/s11060-025-05399-x PMID: 41553596

Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma

Moore-Palhares D, Lawrence LSP, Myrehaug S, Stewart J, Detsky J, Tseng C-L, Chen H, Dinakaran D, Maralani P, Ruschin M

International Journal of Radiation Oncology Biology Physics20258 citationsOpen Access

DOI: 10.1016/j.ijrobp.2025.03.028

Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.

Cloughesy TF, van den Bent MJ, Touat M, Blumenthal DT, Peters KB, Ellingson BM, Clarke JL, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry J, Giglio P, de la Fuente M, Maher E, Bottomley A, Tron AE, Yi D, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Mellinghoff IK, INDIGO trial investigators

The Lancet. Oncology2025

DOI: 10.1016/s1470-2045(25)00472-3 PMID: 41175888

Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

Roth P, Gorlia T, Reijneveld JC, de Vos F, Idbaih A, Frenel J-S, Le Rhun E, Sepulveda JM, Perry J, Masucci GL

Neuro-Oncology202455 citationsOpen Access

DOI: 10.1093/neuonc/noae053

Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival.

Ong WL, Stewart J, Sahgal A, Soliman H, Tseng CL, Detsky J, Chen H, Ho L, Das S, Maralani P, Lipsman N, Stanisz G, Perry J, Lim-Fat MJ, Atenafu EG, Lau A, Ruschin M, Myrehaug S

International journal of radiation oncology, biology, physics202411 citationsOpen Access

DOI: 10.1016/j.ijrobp.2024.03.036 PMID: 38561051

Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis

Moore-Palhares D, Chen H, Keith J, Wang M, Myrehaug S, Tseng C-L, Detsky J, Perry J, Lim-Fat MJ, Heyn C

Journal of Neuro-Oncology202312 citations

DOI: 10.1007/s11060-023-04340-4

Correction to: Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis

Moore-Palhares D, Chen H, Keith J, Wang M, Myrehaug S, Tseng C-L, Detsky J, Perry J, Lim-Fat MJ, Heyn C

Journal of Neuro-Oncology20232 citationsOpen Access

DOI: 10.1007/s11060-023-04364-w

Current state of therapeutic focused ultrasound applications in neuro-oncology.

Meng Y, Pople CB, Budiansky D, Li D, Suppiah S, Lim-Fat MJ, Perry J, Sahgal A, Lipsman N

Journal of neuro-oncology202236 citations

DOI: 10.1007/s11060-021-03861-0 PMID: 34661791

High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report.

Tseng CL, Chen H, Stewart J, Lau AZ, Chan RW, Lawrence LSP, Myrehaug S, Soliman H, Detsky J, Lim-Fat MJ, Lipsman N, Das S, Heyn C, Maralani PJ, Binda S, Perry J, Keller B, Stanisz GJ, Ruschin M, Sahgal A

Frontiers in oncology202234 citationsOpen Access

DOI: 10.3389/fonc.2022.1060098 PMID: 36518316

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

James Perry

Research

Latest papers

Latest funding

Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.

Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma

Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.

Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival.

Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis

Correction to: Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis

Current state of therapeutic focused ultrasound applications in neuro-oncology.

High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A&#xa0;first report.

Pilot RCT study to assess feasibility of "supra-marginal" surgical resection of malignant glioma (G-SUMIT: Glioma Supra Marginal Incision Trial)

Advanced Neurotherapeutics involving MRI Guidance of Transcranial Focused Ultrasound

Frequent collaborators

Arjun Sahgal

Hany Soliman

Pejman Maralani

Pejman Jabehdar Maralani

Sten Myrehaug

Chia-Lin Tseng

Sunit Das

Jay Detsky

Nir Lipsman

Angus Lau

Julia Keith

Mary Lim-Fat

Mark Ruschin

Greg Stanisz

Hanbo Chen

Keyue Ding

Suganth Suppiah

Daniel Moore Freitas Palhares

Gregory Czarnota

Richard Aviv

Nauman Malik

Ying Meng

Shadi Daghighi

Amit Singnurkar

Anish Kapadia

Matylda Machnowska

Paul Sanghera

Warren Mason

Brian Keller

Robert Yeung

Sean Symons

High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report.